Oxybutynin
Medication for overactive bladder / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Ditropan?
Summarize this article for a 10 year old
Oxybutynin, sold as under the brand name Ditropan among others, is an anticholinergic drug primarily used to treat overactive bladder. It is widely considered a first-line therapy for overactive bladder due to its well-studied side effect profile, broad applicability, and continued efficacy over long periods of time. It works similar to tolterodine, darifenacin, and solifenacin, although it is usually preferred over these medications. It is sometimes used off-label for treatment of hyperhidrosis, or excessive sweating. It has also been used off-label to treat bed wetting in children, but this use has declined, as it is most likely ineffective in this role. It is taken by mouth or applied to the skin.
Clinical data | |
---|---|
Trade names | Ditropan, Gelnique, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682141 |
License data |
|
Pregnancy category |
|
Routes of administration | Oral, transdermal |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | 91–93% |
Elimination half-life | 12.4–13.2 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.158.590 |
Chemical and physical data | |
Formula | C22H31NO3 |
Molar mass | 357.494 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Common side effects include dry mouth, constipation, dizziness, trouble sleeping, and urinary tract infections.[1] Serious side effects may include urinary retention and an increased risk of heat stroke.[1] Use in pregnancy appears safe but has not been well studied while use in breastfeeding is of unclear safety.[2] It is an antimuscarinic and works by blocking the effects of acetylcholine on smooth muscle.[1]
Oxybutynin was approved for medical use in the US in 1975.[1] It is available as a generic medication.[3] In 2021, it was the 102nd most commonly prescribed medication in the US, with more than 6 million prescriptions.[4][5]